Article Text

Download PDFPDF
Choroidal nevi in adult Indians: The Central India Eye and Medical Study
  1. Vinay Nangia1,
  2. Jost B Jonas1,2,
  3. Shubhra Agarwal1,
  4. Anshu Khare1,
  5. Sarang Lambat1,
  6. Songhomitra Panda-Jonas1
  1. 1Suraj Eye Institute, Nagpur, Maharashtra, India
  2. 2Department of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Germany VN and JBJ contributed equally.
  1. Correspondence to Dr Vinay Nangia, Suraj Eye Institute, 559, New Colony, Nagpur 440 001, India; nagpursuraj{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A choroidal nevus is a melanocytic choroidal lesion which is less than 5 mm in its largest basal diameter and smaller than 1 mm in its height.1 The clinical importance of choroidal nevi relates to their potential malignant transformation and reported association with visual impairment.2 The reported prevalence of choroidal nevi varies from 0.2% to 30%.3 ,4 Since most data on the prevalence of choroidal nevi did not originate from population-based studies, and because population-based data have not been available particularly for the Indian population, it was the purpose of our study to determine the frequency of choroidal nevi and their associations in a population-based investigation in India.

The Central India Eye and Medical Study is a population based cross sectional study performed in rural Central India.5 The Medical Ethics Committee of the Medical Faculty Mannheim …

View Full Text


  • Contributors Study design: VN, JBJ, SPJ; Collection of data: VN, JBJ, SA, AK, SL; Statistical analysis: VN, JBJ, SPJ; writing the manuscript: VN, JBJ, SPJ; Final approval of manuscript: VN, JBJ, SA, AK, SL, SPJ.

  • Funding This work was supported by unrestricted grants from Om Drishti Trust Nagpur; Heidelberg Engineering Co. Heidelberg, Germany; Rotary Sight Saver Netherlands; Orbis India; and Carl Zeiss Meditec Co., Jena, Germany.

  • Competing interests None.

  • Ethics approval The Medical Ethics Committee of the Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg approved the study and all participants gave informed consent.

  • Provenance and peer review Not commissioned; externally peer reviewed.